. Identification and expression analysis of the human -protocadherin gene in fetal and adult kidneys.
cell adhesion; apical targeting DYNAMIC CHANGES IN CELL ADHESION are requisite for the generation of the three-dimensional structure of the kidney. Three consecutive branching patterns utilizing lateral and bifid branches occur during nephrogenesis (1) . During the generation of a branch, cells must escape the restrictions imposed on them by cell adhesion molecules, the matrix, and the basement membrane and then proliferate. However, despite this requirement for plasticity, cells still need to maintain some adherence to one another. One class of cell adhesion molecules found to be critical for these processes are the cadherins, defined by their calcium-dependant homophilic cell adhesion properties. Their cytoplasmic region binds ␤-catenin and is linked to the actin cytoskeleton through ␣-catenin and actinin (30) .
Several mechanisms exist regulating these adhesive interactions during nephrogenesis (see Ref. 9 for review). These include the rapid assembly of adheren junctions, an increase in the clustering of the adhesive complexes and/or an increase in their affinity, or an alteration in the turnover of the cell junction (14) . Finally, differential expression of the cadherins can drive nephrogenesis by stimulating aggregation of subsets of cells expressing the same type of cadherin (4) . The greater affinity of respective cadherins to each other likely facilitates rearrangements within a cluster of cells. This type of molecular rearrangement is termed "sorting" and is one mechanism of generation of a polar structure, as has been demonstrated within rhombomeres of the central nervous system (28) .
We recently identified a novel cell adhesion molecule from the kidney termed -protocadherin (GenBank accession no. AF221952) (8) . Several aspects of -protocadherin highlight its potential importance in the regulation of such dynamic interactions. Its cDNA encodes a novel integral membrane protein, which contains four cadherin-like ectodomains in its extracellular region, and a triply repeating mucin domain in its longest isoform. The latter domain is known to negatively regulate cadherin function in carcinoma cells (15) . Alternatively, the mucin may also provide specificity for its adhesive interactions by binding to its sugar moiety. This is analogous to the selectin-binding carbohydrate determinants of the mucin domains on mucosal addressin cell adhesion molecule-1 that support the rolling of lymphocytes under shear (3) . A shorter isoform lacks the mucin domain and is independently regulated in the kidney during the perinatal period (8) . Expression of the long isoform in L929 cells results in cell-to-cell aggregation, confirming its role in intercellular adhesion (8) .
We sought to identify the human -protocadherin ortholog and examine its expression in the developing kidney. Members of the cadherin superfamily are numerous and diverse (24) . One identifying criterion dis-tinguishing -protocadherin is the presence of the mucin repeats tandem to the cadherin ectodomains. Basic Local Alignment Search Tool (BLAST) search of the National Center for Biotechnology Information human database detected just one gene, termed MUCDHL, with a comparable extracellular domain. MUCDHL was identified within a 500-kb contig spanning the region between c-HRAS and MUC2 on chromosome 11p15.5 (20) . Identical structural motifs between MUCDHL and -protocadherin, spanning the full length of the protein, provide strong evidence that MUCDHL is the human ortholog of -protocadherin. Confirmation that MUCDHL was the -protocadherin ortholog was made on the basis of rodent-human comparison using fluorescence in situ hybridization (FISH) analysis. Hybridization with a -protocadherinderived mouse bacterial artificial chromosome (BAC) clone localized this gene to distal chromosome 7 band F4 of the mouse, which is syntenic to human 11p15.5.
Pairwise alignment of the human -protocadherin ortholog and expressed sequences in GenBank identified at least three alternatively spliced forms of human -protocadherin. The first two forms differ in the presence of the mucin domain, whereas the third isoform, interestingly, has a shortened 13th exon and lacks the mucin and transmembrane domain. Differential expression of these messages was noted in the kidney and liver by Northern blot analysis. Immunocytochemistry in the adult kidney demonstrated apical expression along the brush border of the proximal convoluted tubule. Localization of this protein to the apical surface can be further demonstrated on transfection of MUCDHL into polarized Madin-Darby canine kidney (MDCK) cells. The NH 2 terminus is essential for this apical targeting. These results suggest that the compartmentalization of human -protocadherin to the apical surface may facilitate additional functions of terminally differentiated epithelia.
METHODS
Materials. Taq polymerase was obtained from Fisher Scientific (Suwanee, GA). Deoxynucleotide primers for PCRs were synthesized by Gene Link (Thornwood, NY). Tris base, glycerol, sodium chloride, and Triton X-100 were from Sigma (St. Louis, MO). Human multiple tissue Northern blots were obtained from Clontech (Palo Alto, CA). Transwell filters were purchased from Corning Costar (Cambridge MA). Paraformaldehyde was purchased from Electron Microscopy Sciences (Ft. Washington, PA). The GC-rich PCR system and Lipofectamine 2000 were purchased from Life Technologies (Rockville, MD)
Cell culture. MDCK cells were grown in DMEM/Ham's F-12 supplemented with FCS. Caco-2 cells were obtained from the American Type Culture Collection and grown in MEM with 2 mM L-glutamine, Earle's balanced salt solution adjusted to contain 1.5 g/l sodium bicarbonate, 0.1 mM nonessential amino acids, 1.0 mM sodium pyruvate, and 20% fetal bovine serum.
FISH analysis of mouse -protocadherin. A genomic BAC clone containing the -protocadherin gene was obtained by screening a mouse BAC library with the cytoplasmic region of mouse -protocadherin derived from GenBank accession no. W18538 (Research Genetics). It was further subcloned, and a 7.5-kb genomic fragment containing, in part, the 5Ј-regulatory region was obtained. This was used to hybridize to mouse metaphase chromosomes. Dual staining with FITClabeled chromosome 7 paint confirmed the identity of the chromosome. Chromosomes were banded by the 4,6-diamidino-2-phenylindole counterstain.
Structural analysis of the human -protocadherin gene. BLAST analysis of the human database identified the human ortholog of -protocadherin (GenBank accession no. AF256874). The exon-intron structure was obtained by pairwise alignment of the human ortholog (AF256874) and mRNAs AF258676, AF276242, and AF258675 using the gap2 program with the GCG server.
Northern blot analysis of -protocadherin. Human fetal blot and multiple adult human tissue Northern blots were obtained from Clontech (Palo Alto, CA). The fetal kidney mRNA was derived from a pool of males and females aged 21-30 wk, fetal liver mRNA aged 18-24 wk, fetal lung aged 20-25 wk, and fetal brain aged 16-32 wk (Dr. Yonca Ilkbahar, Clontech Labs). It was hybridized with the cytoplasmic region of human -protocadherin (GenBank accession no. AI640262). The cytoplasmic insert was 32 P labeled by a random primed reaction. A multiple blot containing mRNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas (Clontech) was also hybridized, but no bands were detected and therefore the results were not illustrated.
Generation of antibodies. Rabbit polyclonal antibodies were generated against the cytoplasmic region of human -protocadherin. A sequence corresponding to amino acids 525-651 of NP_112554 was ligated into pGEX (Amersham Pharmacia, Piscataway, NJ) to create a glutathione S-transferase (GST)-fusion protein and transformed into BL21 Escherichia coli cells. The fusion protein was purified on an immobilized GST column (Pierce), and the amino acid sequence was verified by mass spectroscopy after trypsin digestion. Soluble fusion protein was injected into rabbits for generation of polyclonal antisera (Pocono Rabbit Farm & Laboratory, Canadensis, PA).
Immunoblot analysis. Adult and fetal kidney tissue (Columbia University Cancer Center Tissue Bank) was extracted with SDS-PAGE buffer containing ␤-mercaptoethanol. A preliminary Coomassie-stained gel was performed to equalize the amount of protein that was loaded on each lane (data not shown). Rabbit antibody directed against a GSTfusion protein with the cytoplasmic domain of human -protocadherin was generated and used as the primary antibody. Preimmune serum was used as the negative control. No staining was seen with the preimmune serum (data not shown).
Generation and transient transfection of -protocadherin isoforms. A PCR using GC-rich enzyme and expressed sequence tag (EST) AK-000384 as a template with the primer pair aattaaaagcttcagaccctcctgccaggtgacagccg and aattaacacgtggatgtaggagtcatcaccaccgggcg generated the full-length cDNA of the short isoform of -protocadherin. 3Ј-adenosine overhangs were added with Taq polymerase, and then the PCR product was cloned into the 3Ј-T overhang of a pcDNA3.1/V5-His TOPO targeting vector (Invitrogen, Carlsbad, CA). In a second construct, a stop codon was placed at the 3Ј-terminus to ensure correct termination of translation and cloned into the pcDNA5/FRT/V5-His TOPO targeting vector. The cloning of the mucin containing full-length rat isoform was previously described (8) . PCR reactions utilizing the primer pairs aattaaccgcggaacccttcttccaggtgacagctg and aaatagcggccgcttagtgaaccgatgtcggtagtg, and aatctttccgcggtcatatcaggagtaggcgagctg and aattaagcggccgcacgtaagtgttgtctgcgactg containing KspI and NotI sites at their ends were used to generate NH 2-terminal (lacking intracellular domain) or COOH-terminal (lacking the extracellular domain) forms of rat -protocadherin, respectively. They were then cloned into the KspI and NotI sites of the pHM6 cloning vector, which contains a 3Ј-His tag (Boehringer Mannheim). MDCK cells were seeded the day before onto Transwell filters such that they were 85-90% confluent at the time of transfection. MDCK cells were transfected utilizing Lipofectamine 2000 and then cultured for an additional 48-72 h for transient expression analysis. Under these experimental conditions, MDCK cells form a polarized monolayer, which was confirmed by measurement of their electrical resistance. Filters were then processed for immunocytochemistry.
Immunocytochemistry. The staining protocol was performed as previously described (8), with some minor modifications. Paraformaldehyde-fixed tissue sections (4-5 m thick) were blocked with 100% FCS in PBS before the addition of primary antibody. A high-titer rabbit polyclonal serum directed against -protocadherin was diluted at 1:100 and incubated with sections for 1 h at room temperature. A pool of anti-pancytokeratin mouse monoclonal antibodies, AE1, AE3 (Chemicon), and KL1 (Immunotech), were utilized to identify collecting tubules and visualized after incubation with a rhodamine-conjugated secondary antibody. Monoclonal antibody to neutral endopeptidase was purchased from Coulter Immunology (Hialeah, FL). Caco-2 cells, which endogenously express -protocadherin, were seeded close to confluency and analyzed after 4 days by confocal microscopy. Expression of the truncated forms of -protocadherin in MDCK transfected cells was detected using an anti-His monoclonal antibody. Propidium iodide staining (25 g/ml) was utilized to detect nuclei. Stained monolayers were mounted onto a glass coverslip in fluorescent mounting medium (DAKO) and viewed with an Axiovert 100 laser scanning confocal microscope (model LSM 410, Carl Zeiss). Excitation with an argon-krypton laser in the 488-, 568-, and 645-nm channels was used to visualize fluorescein, rhodamine, or propidium iodide, and Cy5-conjugated secondary antibodies, respectively. Images were collected as 1-m-thick optical sections, and orthogonal sections were generated using Zeiss LSM-PC software. Final images were processed using Adobe Photoshop.
RESULTS

FISH.
To facilitate the study of the -protocadherinmediated pathway and its regulation, a mouse BAC clone containing the -protocadherin gene was obtained. This was used as a first step to identify the human ortholog of -protocadherin by FISH and mouse-human syntenic analysis. Metaphase spreads of mouse chromosomes were hybridized with a rhodamine-labeled -protocadherin-derived mouse BAC clone (Fig. 1) . Signal was seen on both chromosome 7 orthologs on the most distal chromosome band F4. This was confirmed by two-color FISH using a rhodaminelabeled -protocadherin-derived mouse BAC clone and an FITC-labeled chromosome paint probe derived from chromosome 7. Because many and often diverse members constitute the protocadherin superfamily, mapping of the mouse ortholog provided an important clue to the localization of the human -protocadherin gene on the basis of human-mouse synteny. Of possible interest for future studies, the distal end of mouse chromosome 7 is syntenic to 11p15.5, an imprinted region that is often subject to a loss of heterozygosity in Wilms tumors (6) .
Comparison of the amino acid sequence of human and rat -protocadherin orthologs. BLAST search of the human database led initially to two ESTs with homology to rat -protocadherin. (GenBank accession nos. AK000384 and AK000226). These ESTs were subsequently shown to be derived from the MUCDHL gene (GenBank accession no. AF258674) (20) . Overall, there was Ͼ60% identity, and Ͼ70% were positives between the rat and human proteins (data not shown). Regions of identity spanned the full length of the protein.
Closer examination of the structural motifs present in the human protein provides strong evidence that it is the human ortholog of -protocadherin.
The consensus sequence for the -protocadherin cadherin ectodomains is shown in Fig. 2A . The amino acid alignment of the human and rat -protocadherin ectodomains is presented with rat FAT (16) and human protocadherin ␥-a2 for comparison (29) . Blocked letters indicate identical amino acid sequences. Dark and light shading indicate more conserved and less conserved amino acid sequences, respectively. Ectodomains 1-4 are indicated by EC1-EC4, respectively. Numbering refers to the size of the cadherin repeat. Presented in Fig. 2B is a dendogram tree, indicating clustering of ectodomains by similarity. The similarity tree of rat and human -protocadherin ectodomains reveals that respective ectodomains are more similar to each other than to any other cadherin ectodomains obtained by the BLAST search. A comparison is made to its two most closely related ectodomains obtained by the BLAST search, the rat ortholog of the Drosophila melanogaster tumor suppressor FAT and the human protocadherin ␥-a2. These results suggest that rat -protocadherin and the MUCDHL gene are orthologous and may constitute a new subdivision within the cadherin superfamily (19) . The identical structure of the mucin repeats region is noted between the rat (AF221952) and human -protocadherin ortholog (AF258676) (Fig. 2C) . The mucin region is repeated 3.5 times and noted by M1-M4. The mucin domain was shown to be glycosylated in vivo in the rat kidney (8) . On the basis of neural network predictions of mucin-type GalNAc O-glycosylation sites in mammalian proteins (23) , the mucin region of the human -protocadherin gene is similarly predicted to be heavily glycosylated (data not shown). Conservation of the size and number of repeats within the mucin domain between the rat and human ortholog suggests the importance of the secondary structure of -protocadherin in its function.
After the mucin repeat in the long isoform, there is a single transmembrane region and a cytoplasmic region with a conserved tyrosine kinase phosphorylation site (blue) and four SH3 binding regions (red). In the short isoform, the cadherin ectodomains are alternatively spliced to the same transmembrane domain. The cytoplasmic region of rat -protocadherin terminates with a PSD95-Dlg-zona occludens-1 (PDZ) binding domain (orange, Fig. 2C ) similar to the COOH-terminal end of rat fat protocadherin (27) . Conserved amino acids are present at the 3Ј-end of the human form; however, further experimentation will be needed to validate whether it can mediate binding to a PDZ protein.
As a final note of evidence that the human ortholog of -protocadherin was identified, MUCDHL maps to 11p15.5, consistent with an analysis of synteny with distal mouse chromosome 7. The genomic structure of human -protocadherin is presented in Fig. 3 . Three alternatively spliced forms of human -protocadherin were identified in the human kidney. The first two isoforms differ in the presence of the mucin domain similarly to that described for the rat ortholog (8) . The third isoform (AF258675), interestingly, has a shortened 13th exon, lacks the mucin and transmembrane domain (TM in Fig. 3 ), and contains a unique cytoplasmic region. This isoform potentially could encode for a secreted form (the signal sequence is still present) or, alternatively, could be linked to the membrane by a glycosyl phosphatidylinositol (GPI) linkage, although the consensus sequence for GPI linkage was not detected. Although -protocadherin contains many similarities to the protocadherin superfamily (8), the above genomic analysis is in contrast to a large clustering of protocadherin genes in which the genomic sequences are organized in three closely linked clusters that contain variable extracellular domains but a conserved cytoplasmic region (29) .
Expression analysis of human -protocadherin. Tissue expression of human -protocadherin in fetal (Fig.  4A ) and adult human tissue (Fig. 4B ) was analyzed by Northern blot. Blots were hybridized with the cytoplasmic region of a homologous human mouse EST clone (GenBank accession no. 2299669). Three forms are noted in the developing kidney and liver. Interestingly, the longest isoform is primarily expressed in the adult small intestine and colon, whereas in the fetal liver, the strongest expression of the second message is noted. These differences in isoform-specific expression may relate to different stages of development. Although a third blot containing adult kidney tissue was negative using the same probe (data not shown), PCRbased analysis as well as the EST database reveals expression derived from the adult kidney. Interestingly, only a single major isoform is expressed in the adult small intestine and colon. Analysis by Western blot of fetal and adult kidney was performed next (Fig.  5) . Rabbit antibody directed against a GST-fusion protein with the cytoplasmic domain of human -protocadherin was generated and used as the primary antibody. Preimmune serum was used as the negative control. No staining was seen with the preimmune serum (data not shown). In both the fetal and adult kidney, the rabbit polyclonal detected four forms rang- Fig. 3 . Genomic structure of human -protocadherin. The exon-intron structure was obtained by pairwise alignment of the human ortholog (AF256874) and mRNAs (AF258676, AF276242, and AF258675). Lengths of the boxes are proportional to size of the exon. White boxes correspond to 5Ј-and 3Ј-untranslated regions (UTRs), respectively. For AF276242, the 5Ј-UTR structure was unreported. ing from 110 to 220 kd. These multiple forms may be the result of posttranslational modifications and highlight the need to explore the possible different functions of each isoform.
Apical distribution of -protocadherin in differentiated epithelia. Immunocytochemistry in adult kidney revealed -protocadherin is expressed apically along the brush border of the proximal convoluted tubule (green, Fig. 6A ) and excluded from cortical collecting ducts (red, Fig. 6A ). -Protocadherin expression in proximal tubules was confirmed by dual staining with neutral endopeptidase (EC 3.4.24.11) a known brushborder enzyme (Fig. 6C) . Colocalization of these two proteins is seen in Fig. 6D . Localization of this protein to the apical surface can be further demonstrated on transfection of MUCDHL into polarized MDCK cells. MDCK cells were plated onto Transwell filters and allowed to grow until they formed a tightly polarized monolayer. Cells were fixed and stained with anti-zona occludens-1 (tight junction, blue) and anti--protocadherin antibodies (green), mounted in propidium iodide to detect nuclei, and analyzed by confocal microscopy (Fig. 7, A and B) . The X-Z section (bottom) confirms the -protocadherin staining to be apical at or above the tight junction level (blue). This is in contrast to caco-2 cells that have not yet formed such a tightly polarized monolayer. Although some of the staining is apical, the majority is still cytoplasmic. These results demonstrate that human -protocadherin is compartmentalized to the apical surface as cells develop a polarized state and suggest it may have additional functions in terminally differentiated epithelia.
Extracellular domain required for targeting of -protocadherin to the apical surface.
To analyze the sequences required for targeting of -protocadherin to the apical surface, truncated forms lacking the NH 2 or COOH terminus were cloned into the pHM6 mammalian expression vector. All the forms contained the putative transmembrane domain for insertion into the membrane. A his tag on the COOH terminus of the fusion protein allowed for the identification of the protein. As illustrated in Fig. 7C , the mucin-containing isoform, similar to the shorter isoform in Fig. 7A , is directed to the apical surface. Because the former contains a His site at the COOH terminus, this demonstrates that the PDZ binding domain is not required in this system for targeting. Transfection of the truncated form lacking the COOH terminus was still capable of targeting to the apical surface (Fig. 7D) . Deletion of the NH 2 terminus, however, disrupted this targeting, and -protocadherin also localized to the lateral membrane (Fig. 7E) . Thus the extracellular domain is required for targeting of -protocadherin to the apical surface.
DISCUSSION
The cadherin superfamily is composed primarily of six major subfamilies distinguished on the basis of their genomic structure, protein domain composition, and phylogenetic analysis (19) . These include the classic or type-I cadherins, atypical or type-II cadherins, and protocadherins and their mouse counterparts, the cadherin-related neuronal receptors (10), desmocollins, desmogleins, and flamingo cadherins. In addition, isolated cadherin family members include cadherin-13, -15, -16, -17, Dachsous, RET, FAT, MEGF1, and most invertebrate cadherins. One unique identifying feature of -protocadherin is the juxtaposition of a cadherin Fig. 6 . Immunolocalization of human--protocadherin in adult kidneys. A: sections were dually stained with rabbit polyclonal antibodies against -protocadherin (green) and anti-cytokeratin antibodies (red), a marker for the kidney collecting duct. Bar ϭ 30 m. In a colocalization experiment, adult kidney was stained for -protocadherin (green; B) and neutral endopeptidase (EC 3.4.24.11), a known brush-border enzyme (red; C). Colocalization of these two proteins is seen when the two channels are merged (yellow; D) . Bars B-D ϭ 60 m. Fig. 5 . Immunoblot analysis of fetal and adult kidneys. High-titer rabbit antiserum directed against the cytoplasmic domain of human -protocadherin was used as the primary antibody. Incubation with a peroxidase secondary antibody and subsequent enhanced chemiluminescence was performed. In both the fetal and the older kidney, the rabbit polyclonal detected 4 forms ranging from 110 to 220 kd.
domain followed by mucin repeats in its extracellular domain. This mucin-type region structure is conserved between rat and human and contains a 31 amino acid motif that is repeated 3.5 times. As was experimentally observed with the rat -protocadherin ortholog (8), neural network predictions of mucin-type GalNAc Oglycosylation sites in human -protocadherin are that they are heavily glycosylated (data not shown) (23) . In both the rat and the human forms, the mucin region is alternatively spliced to generate a protein with an extracellular region consisting of just the cadherin ectodomains. In addition, the conservation of domain structures between the human and rat forms extend through the cytoplasmic region. After the extracellular domain, the human -protocadherin contains a single transmembrane region and a cytoplasmic region containing four SH3 binding regions, as in the rat -protocadherin gene. This is in contrast to that of human ␣-protocadherin, which contains six (29) . The cytoplasmic tyrosine kinase phosphorylation site is conserved across the rat and human species. The cytoplasmic region of rat -protocadherin terminates with a type I PDZ binding domain, similar to the COOH-terminal end of rat fat protocadherin (22) . Although conserved amino acids are present at the COOH-terminal end of the human form, further experimentation is needed to test whether it can mediate binding to a PDZ protein.
Additional evidence that we indeed identified the ortholog is on the basis of mouse to human synteny and FISH analysis. A mouse BAC clone containing the -protocadherin gene localizes to mouse distal chromosome 7, which is syntenic to the human 11p15.5 region, MDCK cells were transfected with the short isoform of human -protocadherin and analyzed for expression 2 days later. They were stained with anti--protocadherin antibody (green), anti-zona occludens-1 monoclonal antibody (blue), and propidium iodide to detect nuclei (red). X-Z sections demonstrate an apical localization for -protocadherin. B: caco-2 cells that endogenously express -protocadherin were analyzed 4 days after seeding. In contrast to transfected MDCK cells, X-Z sections of caco-2 cells reveal that vesicles in the cytoplasm are also positive. C: MDCK cells were transfected with the mucin-containing isoform of the rat -protocadherin gene (7) and truncated forms lacking the COOH terminus (D) or NH2 terminus (E). A his tag on the COOH terminus of the fusion protein was utilized for identification of -protocadherin. Deletion of the NH2 terminus (E) disrupts apical targeting, and X-Z sections reveal -protocadherin now also localizes to the lateral membrane. Bars ϭ 10 m.
the site of the MUCDHL gene. Thus the previously described MUCDHL gene is the human ortholog of -protocadherin and may represent a new subdivision within the cadherin superfamily.
A second unique feature of -protocadherin is its apical distribution in terminally differentiated epithelia. Structural information for apical sorting of the transmembrane neurotrophin receptors (p75) is localized to a juxtamembrane region of the extracellular domain that is rich in O-glycosylated serine/threonine residues (31), suggesting that the mucin repeats in -protocadherin may play a similar role. However, both the long and the short isoform of -protocadherin are targeted to the apical surface in polarized cells, suggesting that the mucin region is not required for targeting to the apical membrane. The NH 2 terminus, however, is clearly essential, because a truncated form lacking it is targeted to the lateral membrane as well. Another potential sorting signal on -protocadherin is its PDZ binding domain at the COOH terminus. For example, the PDZ interacting domain of the cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane (17) . In contrast, the constructs reported here were fusion proteins with his tags masking the PDZ binding domain, revealing that the apical targeting was independent of such a signal. In a different mucin-like protein, endolyn, an N-glycan-dependent apical targeting signal in the lumenal domain, is responsible for direction to the apical surface of polarized epithelial cells, after which it is then processed to a novel biosynthetic pathway to lysosomes (11) . Similarly, N-glycosylation sites located in the large extracellular loop of glycine transporter isoform-2 are involved in apical localization in polarized MDCK cells. (33) . Thus future experiments will explore the potential role of the five N-glycosylation sites on the extracellular domain of -protocadherin in its apical targeting. It is of interest that the glycosyl phosphatidylinositollinked T-cadherin is differentially targeted to the apical surface of the chick intestinal epithelium in vivo, suggesting the cadherin superfamily may have functional roles in addition to mediating cell-to-cell adhesion (13) .
The multiplicity of -protocadherin isoforms suggests that this protocadherin subfamily may have several functional roles. The longer isoform (containing the mucin moiety) in rats was capable of mediating aggregation in L cells (8) . Similar to other protocadherins, however, the aggregation was not as robust as that reported for E-cadherin (24) . Preliminary experiments with the short isoform of human -protocadherin (lacking the mucin moiety) reveal it can mediate sorting of expressing cells from nonexpressing cells (data not shown). Because of the complex biological versatility of the sialomucins, a comparison between these two isoforms and their kinetics of aggregation may be more revealing. Mucins, for instance, have been shown to interfere with E-cadherin-mediated cell-tocell adhesion (15) . It is therefore possible that the mucin repeats on -protocadherin may regulate the adhesion mediated by the cadherin ectodomains. In addition, however, their oligosaccharide side chains, which protrude above the glycocalyx, can interact with ligands on opposing cells and facilitate cell-to-cell adhesion (26, 27) . The glycosylation status of the cadherins also has a profound effect on the transduction of its signal into the cell. The addition of a bisecting N-acetylglucosamine residue on E-cadherin enhanced cell-to-cell aggregation, suppressing metastasis in B16 melanoma cells (32). The molecular mechanism was the downregulation of tyrosine phosphorylation on ␤-catenin, resulting in decreased cell migration (12) . Thus any functional analysis of -protocadherin will likely require the identification of its posttranslational modifications in vivo. The function of the third form, which splices out the mucin and transmembrane domain to combine a truncated fourth ectodomain to a unique 3Ј-end, requires further investigation. The potential exists that this protein could be secreted or, alternatively, could be attached to the membrane through a GPI linkage, although there is no apparent recognition sequence for the latter. Because both the probe for Northern blot analysis and the fusion protein generated for the production of the polyclonal antibodies were derived from the cytoplasmic sequences of the first two isoforms, the expression pattern of the third isoform remains to be determined.
The functional role for -protocadherin in vivo in the adult kidney is intriguing, because lateral expression of the molecule would more likely facilitate an adhesive interaction. One possibility is that while in an apical localization, the heavily negative sialated residues could serve in part to orient cells within a complex and facilitate aggregation through other cell adhesion molecules. -Protocadherin is not the only cadherin that localizes to the apical membrane. For example, in vivo, T-cadherin was detected on the apical cell surface of the chick intestinal epithelium (13) . T-cadherin is a glycophosphoinositol-anchored protein noted to be found in specialized cell membrane domains rich in signaling molecules, termed lipid rafts (7) . In vascular smooth muscle cells, T-cadherin was found to be associated with signal transducing effector molecules, such as SRC family kinases and G␣ s protein (21) . Other cadherin superfamily members implicated as signaling molecules are the seven-transmembrane (7-TM) cadherins, such as starry night and flamingo in Drosophila (25) and the mammalian paralog human MEGF2 (18). 7-TM cadherins contain seven predicted transmembrane domains with high homology to G-protein-coupled receptors and thus could potentially regulate intracellular cAMP and cGMP levels. -Protocadherin contains proline-rich regions in its cytoplasmic domain that may interact with SH3 domains in nonreceptor tyrosine kinases; therefore, a role for -protocadherin in cell signaling will be explored.
A second cadherin molecule localizing to the apical membrane is human peptide transporter-1 (5). Human peptide transporter-1, which has an affinity for dipeptides, is associated with intestinal peptide transport and contains four cadherin-like domains in its extracellular region, similar to that seen in -protocadherin. The ability of a cadherin to directly function as a ligand-specific receptor is perhaps best illustrated by the protocadherin ret, which binds GDNF. Recent molecular modeling of the RET sequence again delineated four distinct NH 2 -terminal domains, each of ϳ110 residues, containing many of the consensus motifs of the cadherin fold (2) . -Protocadherin that is expressed on the brush border of the proximal tubule, therefore, would be ideally situated to function as a ligand-specific receptor for a molecule filtered by the glomerulus.
Cadherins are critical for processes such as embryonic patterning, maintenance of tissue integrity, generation of three-dimensional structure, and control of cell growth. The human -protocadherin gene maps to 11p15.5, an imprinting region (6) . This region also contains loss of heterozygosity regions in Wilms tumors and the locus of Beckwith-Wiedmann syndrome (a congenital anomaly consisting of somatic overgrowth, urogenital abnormalities, and a predisposition to development of tumors). The identification of the human ortholog of -protocadherin is the first step in studying its role in kidney development and disease.
